These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1336994)

  • 1. Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporin-A.
    Bernton E; Bryant H; Holaday J; Dave J
    Brain Behav Immun; 1992 Dec; 6(4):394-408. PubMed ID: 1336994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteamine produces dose-related bidirectional immunomodulatory effects in mice.
    Bryant HU; Holaday JW; Bernton EW
    J Pharmacol Exp Ther; 1989 May; 249(2):424-9. PubMed ID: 2724132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice.
    Bernton EW; Meltzer MS; Holaday JW
    Science; 1988 Jan; 239(4838):401-4. PubMed ID: 3122324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoregulatory effects of prolactin in mice are time of day dependent.
    Cincotta AH; Knisely TL; Landry RJ; Miers WR; Gutierrez PJ; Esperanza P; Meier AH
    Endocrinology; 1995 May; 136(5):2163-71. PubMed ID: 7720666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteamine induces depletion of both immunological and biological prolactin activity in the anterior pituitary and blood of the rat.
    Millard WJ; Sagar SM; Simpkins JW; Owens RE; Badger TM; Friesen HG; Martin JB
    Endocrinology; 1983 Dec; 113(6):2161-7. PubMed ID: 6641630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro.
    Morikawa K; Oseko F; Morikawa S
    Clin Exp Immunol; 1994 Mar; 95(3):514-8. PubMed ID: 8137548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of bromocriptine administration to mothers on the development of pup thymocyte and splenocyte subsets and on mitogen-induced proliferation in the mouse.
    Gala RR; Shevach EM
    Life Sci; 1993; 53(26):1981-94. PubMed ID: 8255161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metoclopramide and bromocriptine on prolactin secretion in the pregnant ewe.
    Fitzgerald BP; Cunningham FJ
    J Endocrinol; 1982 Apr; 93(1):41-6. PubMed ID: 7069345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New aspects of androgens, prolactin, and ACTH interaction in men.
    Magrini G; Iselin H; Ebiner JR; Felber JP
    Arch Androl; 1979 Mar; 2(2):141-55. PubMed ID: 226014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine.
    Hiestand PC; Mekler P; Nordmann R; Grieder A; Permmongkol C
    Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2599-603. PubMed ID: 2939454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timed daily administration of prolactin and corticosteroid hormone reduces murine tumor growth and enhances immune reactivity.
    Keisari Y; Cincotta E; Meier AH; Cincotta AH
    Chronobiol Int; 1999 May; 16(3):315-33. PubMed ID: 10373101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteamine-induced depletion of somatostatin and prolactin.
    Millard WJ; Sagar SM; Martin JB
    Fed Proc; 1985 Jun; 44(9):2546-50. PubMed ID: 2860016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and growth hormone levels in different inbred strains of mice: patterns in association with estrous cycle, time of day, and perphenazine stimulation.
    Sinha YN; Salocks CB; Vanderlaan WP
    Endocrinology; 1975 Nov; 97(5):1112-22. PubMed ID: 1237395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prolactin on the luteinizing hormone response to gonadotropin- releasing hormone in primary pituitary cell cultures during the ovine annual reproductive cycle.
    Gregory SJ; Townsend J; McNeilly AS; Tortonese DJ
    Biol Reprod; 2004 May; 70(5):1299-305. PubMed ID: 14695904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 22K variant of rat prolactin: evidence for identity to prolactin-(1-173), storage in secretory granules, and regulated release.
    Anthony PK; Stoltz RA; Pucci ML; Powers CA
    Endocrinology; 1993 Feb; 132(2):806-14. PubMed ID: 8425495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of pituitary prolactin by cysteamine is due to loss of immunological activity.
    Scammell JG; Dannies PS
    Endocrinology; 1984 Mar; 114(3):712-6. PubMed ID: 6697959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function.
    Tsai SJ; Loeffler DA; Heppner GH
    Cancer Res; 1992 Apr; 52(8):2209-15. PubMed ID: 1559224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo.
    Krishnan N; Thellin O; Buckley DJ; Horseman ND; Buckley AR
    Endocrinology; 2003 May; 144(5):2102-10. PubMed ID: 12697719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of bovine pituitary prolactin by cysteamine involves a thiol:disulfide mechanism.
    Lorenson MY; Jacobs LS
    Endocrinology; 1984 Oct; 115(4):1492-5. PubMed ID: 6479100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin: a novel and safe immunomodulating hormone for the treatment of immunodepression following severe hemorrhage.
    Zellweger R; Wichmann MW; Ayala A; DeMaso CM; Chaudry IH
    J Surg Res; 1996 Jun; 63(1):53-8. PubMed ID: 8661172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.